<i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> Hot-Spot Mutations in Relation to Sidedness of Primary Colorectal Cancer: A Retrospective Cohort Study

<b>Background/Objective:</b> Studies have shown an association between colorectal cancer (CRC) sidedness and gene mutations that may affect CRC clinical behavior. This study examined the association between specific <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</...

Full description

Saved in:
Bibliographic Details
Main Authors: Omer Abdelgadir, Yong-Fang Kuo, Anthony O. Okorodudu, M. Firoze Khan, Yu-Wei Cheng, Jianli Dong
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/15/2/142
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588725421342720
author Omer Abdelgadir
Yong-Fang Kuo
Anthony O. Okorodudu
M. Firoze Khan
Yu-Wei Cheng
Jianli Dong
author_facet Omer Abdelgadir
Yong-Fang Kuo
Anthony O. Okorodudu
M. Firoze Khan
Yu-Wei Cheng
Jianli Dong
author_sort Omer Abdelgadir
collection DOAJ
description <b>Background/Objective:</b> Studies have shown an association between colorectal cancer (CRC) sidedness and gene mutations that may affect CRC clinical behavior. This study examined the association between specific <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> hot-spot mutations and primary CRC sidedness. <b>Methods:</b> We performed a retrospective cohort analysis of 722 patients diagnosed with primary CRC and tested for <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> hot-spot mutations at the University of Texas Medical Branch (UTMB) from January 2016 through July 2023. Multivariable logistic regressions analyses were conducted. <b>Results:</b><i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> hot-spot mutations rates were 37.8%, 4.6%, and 6.1%, respectively. Right-sided primary CRC had the highest prevalence of mutated tumors (64%). <i>KRAS</i> and <i>BRAF</i> hot-spot mutations were significantly different according to tumor sidedness. <i>KRAS</i> p.Gly12Asp, p.Gly12Val, and p.Gly13Asp showed a significantly increased likelihood of right-sided primary CRC compared to <i>KRAS</i> wildtype, 128%, 134%, and 221% higher, respectively. Conversely, <i>KRAS</i> p.Gly12Val and p.Gly13Asp mutations were associated with decreased likelihood of rectal cancer (53% lower) and left-sided tumors (56% lower), respectively. <i>BRAF</i> p.Val600Glu mutation, as opposed to <i>BRAF</i> wildtype, was associated with a 278% higher likelihood of right-sided CRC. No significant associations were observed between <i>NRAS</i> mutations and primary CRC sidedness. <b>Conclusions:</b> In primary CRC, specific mutations in <i>KRAS</i> (p.Gly12Asp, p.Gly12Val, and p.Gly13Asp) and <i>BRAF</i> p.Val600Glu were associated with increased likelihood of right-sided tumors. <i>KRAS</i> p.Gly12Val and p.Gly13Asp mutations were associated with decreased likelihood of rectal cancer and left-sided tumors, respectively. These findings suggest that tumorigenesis and mutational processes differ based on tumor sidedness. Further studies are needed to substantiate these findings.
format Article
id doaj-art-c88dc9ef572342bc9c4a095a404db3cc
institution Kabale University
issn 2075-4418
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj-art-c88dc9ef572342bc9c4a095a404db3cc2025-01-24T13:28:52ZengMDPI AGDiagnostics2075-44182025-01-0115214210.3390/diagnostics15020142<i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> Hot-Spot Mutations in Relation to Sidedness of Primary Colorectal Cancer: A Retrospective Cohort StudyOmer Abdelgadir0Yong-Fang Kuo1Anthony O. Okorodudu2M. Firoze Khan3Yu-Wei Cheng4Jianli Dong5Graduate School of Biomedical Science, University of Texas Medical Branch, Galveston, TX 77555, USASchool of Public and Population Health, University of Texas Medical Branch, Galveston, TX 77555, USADepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USADepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USADepartment of Laboratory Medicine, Cleveland Clinic, Cleveland, OH 44195, USADepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA<b>Background/Objective:</b> Studies have shown an association between colorectal cancer (CRC) sidedness and gene mutations that may affect CRC clinical behavior. This study examined the association between specific <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> hot-spot mutations and primary CRC sidedness. <b>Methods:</b> We performed a retrospective cohort analysis of 722 patients diagnosed with primary CRC and tested for <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> hot-spot mutations at the University of Texas Medical Branch (UTMB) from January 2016 through July 2023. Multivariable logistic regressions analyses were conducted. <b>Results:</b><i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> hot-spot mutations rates were 37.8%, 4.6%, and 6.1%, respectively. Right-sided primary CRC had the highest prevalence of mutated tumors (64%). <i>KRAS</i> and <i>BRAF</i> hot-spot mutations were significantly different according to tumor sidedness. <i>KRAS</i> p.Gly12Asp, p.Gly12Val, and p.Gly13Asp showed a significantly increased likelihood of right-sided primary CRC compared to <i>KRAS</i> wildtype, 128%, 134%, and 221% higher, respectively. Conversely, <i>KRAS</i> p.Gly12Val and p.Gly13Asp mutations were associated with decreased likelihood of rectal cancer (53% lower) and left-sided tumors (56% lower), respectively. <i>BRAF</i> p.Val600Glu mutation, as opposed to <i>BRAF</i> wildtype, was associated with a 278% higher likelihood of right-sided CRC. No significant associations were observed between <i>NRAS</i> mutations and primary CRC sidedness. <b>Conclusions:</b> In primary CRC, specific mutations in <i>KRAS</i> (p.Gly12Asp, p.Gly12Val, and p.Gly13Asp) and <i>BRAF</i> p.Val600Glu were associated with increased likelihood of right-sided tumors. <i>KRAS</i> p.Gly12Val and p.Gly13Asp mutations were associated with decreased likelihood of rectal cancer and left-sided tumors, respectively. These findings suggest that tumorigenesis and mutational processes differ based on tumor sidedness. Further studies are needed to substantiate these findings.https://www.mdpi.com/2075-4418/15/2/142<i>KRAS</i><i>NRAS</i><i>BRAF</i>hot-spot mutationcolorectal cancertumor sidedness
spellingShingle Omer Abdelgadir
Yong-Fang Kuo
Anthony O. Okorodudu
M. Firoze Khan
Yu-Wei Cheng
Jianli Dong
<i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> Hot-Spot Mutations in Relation to Sidedness of Primary Colorectal Cancer: A Retrospective Cohort Study
Diagnostics
<i>KRAS</i>
<i>NRAS</i>
<i>BRAF</i>
hot-spot mutation
colorectal cancer
tumor sidedness
title <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> Hot-Spot Mutations in Relation to Sidedness of Primary Colorectal Cancer: A Retrospective Cohort Study
title_full <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> Hot-Spot Mutations in Relation to Sidedness of Primary Colorectal Cancer: A Retrospective Cohort Study
title_fullStr <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> Hot-Spot Mutations in Relation to Sidedness of Primary Colorectal Cancer: A Retrospective Cohort Study
title_full_unstemmed <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> Hot-Spot Mutations in Relation to Sidedness of Primary Colorectal Cancer: A Retrospective Cohort Study
title_short <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> Hot-Spot Mutations in Relation to Sidedness of Primary Colorectal Cancer: A Retrospective Cohort Study
title_sort i kras i i nras i and i braf i hot spot mutations in relation to sidedness of primary colorectal cancer a retrospective cohort study
topic <i>KRAS</i>
<i>NRAS</i>
<i>BRAF</i>
hot-spot mutation
colorectal cancer
tumor sidedness
url https://www.mdpi.com/2075-4418/15/2/142
work_keys_str_mv AT omerabdelgadir ikrasiinrasiandibrafihotspotmutationsinrelationtosidednessofprimarycolorectalcanceraretrospectivecohortstudy
AT yongfangkuo ikrasiinrasiandibrafihotspotmutationsinrelationtosidednessofprimarycolorectalcanceraretrospectivecohortstudy
AT anthonyookorodudu ikrasiinrasiandibrafihotspotmutationsinrelationtosidednessofprimarycolorectalcanceraretrospectivecohortstudy
AT mfirozekhan ikrasiinrasiandibrafihotspotmutationsinrelationtosidednessofprimarycolorectalcanceraretrospectivecohortstudy
AT yuweicheng ikrasiinrasiandibrafihotspotmutationsinrelationtosidednessofprimarycolorectalcanceraretrospectivecohortstudy
AT jianlidong ikrasiinrasiandibrafihotspotmutationsinrelationtosidednessofprimarycolorectalcanceraretrospectivecohortstudy